Stocks · Health care · Biological Products, (No Diagnostic Substances)

PharmaCyte Biotech, Inc.

PMCB Clue Score43

United States Fiscal year ends April CIK 0001157075

Add to watchlist

What the insiders did Net buying

By person

5 insiders · 6 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Joshua Silverman

CEO and President

$80.48K (3)

—

+$80.48K

416,250

3.88%

$351.15K

—

Jonathan Schechter

Director

$48.23K (3)

—

+$48.23K

192,500

1.79%

$162.39K

+285.0%

Robert Weinstein

Director

—

—

—

41,250

0.3842%

$34.80K

—

Michael M Abecassis

Director

—

—

—

22,292

0.2076%

$18.81K

+1,237%

Wayne Remell Walker

Director

—

—

—

20,625

0.1921%

$17.40K

—